tradingkey.logo

Lifecore Biomedical Inc

LFCR
7.570USD
+0.010+0.13%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
283.62MMarktkapitalisierung
VerlustKGV TTM

Lifecore Biomedical Inc

7.570
+0.010+0.13%

mehr Informationen über Lifecore Biomedical Inc Unternehmen

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Inc Informationen

BörsenkürzelLFCR
Name des UnternehmensLifecore Biomedical Inc
IPO-datumFeb 15, 1996
CEOJosephs (Paul)
Anzahl der mitarbeiter406
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 15
Addresse3515 Lyman Boulevard
StadtCHASKA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55318
Telefon19523684300
Websitehttps://www.lifecore.com/
BörsenkürzelLFCR
IPO-datumFeb 15, 1996
CEOJosephs (Paul)

Führungskräfte von Lifecore Biomedical Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+100000.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+29568.00%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+10494.00%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-215000.00%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-19506.00%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-19506.00%
Katrina L. Houde
Katrina L. Houde
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Christopher S. Kiper
Mr. Christopher S. Kiper
Independent Director
Independent Director
--
-28069.00%
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+100000.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+29568.00%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+10494.00%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-215000.00%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-19506.00%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-19506.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Mar 4
Währung: USDAktualisiert: Tue, Mar 4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
Nach RegionUSD
Name
Umsatz
Anteil
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
Andere
1.50M
5.43%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%

Aktionärsstatistik

Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.91%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
Andere
54.83%
Aktionäre
Aktionäre
Anteil
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.91%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
Andere
54.83%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
30.73%
Investment Advisor
24.01%
Investment Advisor/Hedge Fund
18.36%
Research Firm
1.93%
Individual Investor
1.85%
Private Equity
0.17%
Bank and Trust
0.11%
Pension Fund
0.05%
Insurance Company
0.01%
Andere
22.76%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
212
28.16M
75.16%
-1.82M
2025Q3
203
28.27M
75.45%
-763.44K
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Wynnefield Capital, Inc.
4.70M
12.55%
--
--
Sep 30, 2025
Legion Partners Asset Management, LLC
4.46M
11.91%
+30.00K
+0.68%
Sep 30, 2025
Greenhaven Road Investment Management, L.P.
3.69M
9.86%
--
--
Sep 30, 2025
325 Capital LLC
2.16M
5.77%
--
--
Sep 30, 2025
Laughing Water Capital, LP
1.90M
5.07%
--
--
Sep 02, 2025
David Capital Partners, LLC
1.80M
4.81%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.69M
4.51%
-32.22K
-1.87%
Sep 30, 2025
The Vanguard Group, Inc.
1.62M
4.33%
+12.85K
+0.80%
Sep 30, 2025
Geode Capital Management, L.L.C.
773.63K
2.06%
-1.86K
-0.24%
Sep 30, 2025
GrizzlyRock Capital, LLC
738.88K
1.97%
+4.35K
+0.59%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Motley Fool Next Index ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Mehr Anzeigen
iShares Micro-Cap ETF
Anteil0.04%
WisdomTree US SmallCap Fund
Anteil0.03%
Global X Russell 2000 ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Motley Fool Next Index ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI